Display options
Cite
Hild-Petito S, Donnelly KM, Miller JB, et al. A Baboon (Papio anubis) simulated-pregnant model: cell specific expression of insulin-like growth factor binding protein-1 (IGFBP-1), type I IGF receptor (IGF-1 R) and retinol binding protein (RBP) in the uterus. Endocrine. 1995;3(9):639-51doi: 10.1007/BF02746340.
Hild-Petito, S., Donnelly, K. M., Miller, J. B., Verhage, H. G., & Fazleabas, A. T. (1995). A Baboon (Papio anubis) simulated-pregnant model: cell specific expression of insulin-like growth factor binding protein-1 (IGFBP-1), type I IGF receptor (IGF-1 R) and retinol binding protein (RBP) in the uterus. Endocrine, 3(9), 639-51. https://doi.org/10.1007/BF02746340
Hild-Petito, S, et al. "A Baboon (Papio anubis) simulated-pregnant model: cell specific expression of insulin-like growth factor binding protein-1 (IGFBP-1), type I IGF receptor (IGF-1 R) and retinol binding protein (RBP) in the uterus." Endocrine vol. 3,9 (1995): 639-51. doi: https://doi.org/10.1007/BF02746340
Hild-Petito S, Donnelly KM, Miller JB, Verhage HG, Fazleabas AT. A Baboon (Papio anubis) simulated-pregnant model: cell specific expression of insulin-like growth factor binding protein-1 (IGFBP-1), type I IGF receptor (IGF-1 R) and retinol binding protein (RBP) in the uterus. Endocrine. 1995 Sep;3(9):639-51. doi: 10.1007/BF02746340. PMID: 21153222.
Copy Download .nbib Format: NLM
Share it on

Endocrine. 1995 Sep;3(9):639-51. doi: 10.1007/BF02746340.

A Baboon (Papio anubis) simulated-pregnant model: cell specific expression of insulin-like growth factor binding protein-1 (IGFBP-1), type I IGF receptor (IGF-1 R) and retinol binding protein (RBP) in the uterus.

Endocrine

S Hild-Petito, K M Donnelly, J B Miller, H G Verhage, A T Fazleabas

Affiliations

  1. Department of Obstetrics and Gynecology, University of Illinois College of Medicine, Chicago, Illinois.

PMID: 21153222 DOI: 10.1007/BF02746340

Abstract

In order to test the hypothesis that the baboon conceptus/placenta regulates the synthesis of specific proteins in the endometrium, we developed a simulated-pregnant baboon model. Baboons (n=2-6/group) were treated with increasing amounts of human chorionic gonadotrophin (hCG) for 10 or 12 days beginning on day 6 or 7 PO. Uterine tissues were obtained at day 18 PO following 12 days of hCG treatment. Animals in the day 25 and 32 PO group were treated for 10 days with hCG. Following the hCG treatment, estradiol (E) and progesterone (P) implants were inserted subcutaneously. Control groups consisted of E and P treatment only (day 25 PO), or ovariectomy on day 6 or 7 PO followed by hCG plus E and P treatment (days 18 and 25 PO). Serum samples were obtained daily or once every 2 days and analysed for E and P by radioimmunoassay. hCG activity in serum was determined by a Leydig cell bioassay. Portions of the endometrial tissue were either subjected to organ explant culture, analysed by immunocytochemistry or extracted for RNA. Peripheral serum levels of hCG, E and P in the experimental groups fell within the 95% confidence interval limits of hormone concentrations achieved during pregnancy. The morphology of the endometrium in the hCG treated baboons and pregnant baboons was similar i.e., distended convoluted glands, many spiral artery beds, a loose vacuolized stroma, and increased collagen staining. However, in the absence of hCG (E+P treatment only) the glands tended to be straight rather than corkscrew-shaped, and decreased stromal vacuolization and collagen staining was evident.(35)S-methionine labeled proteins in explant culture conditioned media (TCM) were analysed by two-dimensional SDS-PAGE and fluorography. A comparable pattern of protein synthesis was apparent in all treatment groups except for a low molecular weight (27 000-30 000 daltons) group of polypetides which only was evident in TCM from the hCG treated baboons. A similar group of proteins are also secreted by the baboon endometrium during pregnancy. The immunocytochemical localization of estrogen (ER) and progesterone receptors (PR) was comparable to that observed in pregnant baboons. IGFBP-1 localization was confined to the glandular epithelium in the hCG treated groups (intact and ovariectomized) and was virtually undetectable in the E and P treated group. The intensity of IGFBP-1 staining was variable within each of the hCG treatment groups on days 18, 25 and 32 PO. This variability was also apparent by Western blot analysis, immunoassay of proteins in TCM and on Northern blots of total RNA from the same animals. In contrast, IGF-I R immunostaining was evident in both glandular and surface epithelium of all treatment groups. Expression of RBP was confined to the basal glands. The characteristic upregulation of RBP synthesis in the functionalis observed during early pregnancy was not apparent in any of the treatment groups. In summary, these studies indicate that exogenous hCG in conjunction with E and P, can induce the general morphological and biosynthetic changes the baboon endometrium undergoes during early pregnancy. In addition, this hormonal treatment is also capable of maintaining the epithelial expression of IGFBP-1, IGF-1 and RBP. However, other factors from the conceptus appear to be necessary to induce the cell specific changes in the expression of these three proteins that are observed during pregnancy.

References

  1. Biol Reprod. 1993 Oct;49(4):695-704 - PubMed
  2. J Clin Endocrinol Metab. 1990 Feb;70(2):421-30 - PubMed
  3. Biol Reprod. 1993 Oct;49(4):653-65 - PubMed
  4. Anal Biochem. 1986 Apr;154(1):138-43 - PubMed
  5. Development. 1994 May;120(5):1071-83 - PubMed
  6. Mol Reprod Dev. 1994 Jun;38(2):148-52 - PubMed
  7. Biol Reprod. 1992 Feb;46(2):208-19 - PubMed
  8. Development. 1989 Jul;106(3):555-9 - PubMed
  9. Biol Reprod. 1994 Apr;50(4):791-801 - PubMed
  10. Endocrinology. 1992 Apr;130(4):2354-62 - PubMed
  11. Endocrinology. 1989 May;124(5):2321-9 - PubMed
  12. Biol Reprod. 1987 Nov;37(4):979-88 - PubMed
  13. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed
  14. Contrib Embryol. 1949 Feb;33(213-221):169-86 - PubMed
  15. Biol Reprod. 1980 May;22(4):955-63 - PubMed
  16. J Soc Gynecol Investig. 1994 Oct-Dec;1(4):277-84 - PubMed
  17. AMA Arch Pathol. 1954 Aug;58(2):112-28 - PubMed
  18. J Clin Endocrinol Metab. 1986 Nov;63(5):1211-7 - PubMed
  19. Endocrinology. 1988 Mar;122(3):1165-75 - PubMed
  20. Am J Obstet Gynecol. 1988 Feb;158(2):328-32 - PubMed
  21. J Clin Endocrinol Metab. 1992 May;74(5):1005-11 - PubMed
  22. Endocrinology. 1984 Jun;114(6):2175-82 - PubMed
  23. Endocrinology. 1992 Apr;130(4):2343-53 - PubMed
  24. Endocrinology. 1994 Jul;135(1):76-82 - PubMed
  25. Endocrinology. 1994 Feb;134(2):971-81 - PubMed
  26. Endocrinology. 1992 Jun;130(6):3459-66 - PubMed
  27. Mol Endocrinol. 1991 Oct;5(10):1533-40 - PubMed
  28. J Reprod Fertil. 1990 Mar;88(2):721-31 - PubMed
  29. Biol Reprod. 1988 Oct;39(3):729-36 - PubMed
  30. Endocrinology. 1994 Jul;135(1):107-12 - PubMed
  31. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5115-9 - PubMed
  32. Biol Reprod. 1994 Jun;50(6):1207-15 - PubMed
  33. Biol Reprod. 1993 Oct;49(4):737-42 - PubMed
  34. Endocr Rev. 1980 Summer;1(3):268-94 - PubMed
  35. Mol Endocrinol. 1992 Jan;6(1):101-11 - PubMed
  36. Fertil Steril. 1990 Dec;54(6):1162-7 - PubMed
  37. J Reprod Fertil. 1987 Nov;81(2):327-36 - PubMed
  38. Anal Biochem. 1992 Apr;202(1):40-5 - PubMed

Publication Types